Platform
Team
News
Partnership
Careers
Contact
In the news
Press releases
In the news
Strand Therapeutics targeting solid tumors with its MIT born technology
Strand Therapeutics on its Bristol-Myers Squibb LabCentral Golden Ticket Win
CNBC Health and Science
Push for patent waivers is 'political theater' and won't solve vaccine shortage, CEO says
Bloomberg
States Hit by Mad Dash for Gasoline Amid Crisis (Podcast)
Business Insider
Germany is not happy with Biden's support for waiving COVID-19 vaccine patents, predicting severe complications
Business Insider
Global leaders want to override COVID-19 vaccine patents to boost production. It probably isn't going to work.
Bloomberg
Building Vaccines to Counter Future Pandemics (Podcast)
Forbes
Breakthrough Bottlenecks: Deploying Cell Therapies Like 5G And The Case For Biotechnology Infrastructure
Reuters
Money, talent flowing into mRNA sector after COVID-19 success
CNBC
Strand CEO Jake Becraft on Squawk Box Asia talks mRNA Vaccines and BeiGene licensing deal
Healthline
How COVID-19 Technology May Help Fight Cancer in the Near Future
BioWorld
Strand Therapeutics weaves together synthetic biology, mRNA
Business Insider
A reinvigorated Alzheimer's treatment and gene-therapy setbacks: 3 winners and 3 losers
Forbes
Declaring War on Infectious Disease: The Case For A Vaccine Manhattan Project
Forbes
From Here To Cured: What Will Post-Pandemic Biotech Look Like?
In Vivo
Lessons From Biotech Entrepreneurs: Pitching Your First-In-Class Innovation
BioSpace
Strand Therapeutics’ mRNA Logic Circuits Enhance Gene Therapy’s Safety, Ease and Controllability
Medium
Becoming a Post-Pandemic Species
The Coronavirus Pandemic
Coronavirus: in search for vaccine, US small firms take a leading role
Merger Market
Global biotech and pharma leverage pipelines for COVID-19, but no quick win solutions - Analysis
Med City News
Among Covid-19 vaccine technologies, mRNA represents faster, easier approach, some experts say
Medium
Strand Therapeutics — Genetically Programming mRNA
Boston Business Journal
MIT gene-therapy spinout raises $6M
FinSME
Strand Therapeutics Raises $6M in Seed Funding
BIOCENTURY
Strand’s smart mRNA
Fierce Biotech
Improving cancer immunotherapy by controlling RNA expression
GEN Edge
RNA-Based Gene Therapy Can Be Turned ON or OFF via Synbio Switches
Press release
Business Wire
Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid Tumor Immuno-Oncology Therapeutics Based on Strand’s Next-Generation, Multi-Functional mRNA Technology
January 11, 2021
Business Wire
Strand Therapeutics Appoints Dr. Dane Wittrup to Scientific Advisory Board and Dr. Mark Frohlich to Newly Formed Clinical Advisory Board
March 11, 2020
Business Wire
Strand Therapeutics Announces $6 Million Seed Financing to Advance its Programmable mRNA Therapeutics Platform
June 04, 2019
contact@strandtx.com
237 Putnam Ave
Cambridge, MA 02139 USA
Copyright 2020. Designed in California
Strand Therapeutics Inc. All Rights Reserved
